Total | All-cause mortality | Cardiovascular mortality | Non-cardiovascular mortality | |||||||
---|---|---|---|---|---|---|---|---|---|---|
cholesterol (mmol/l) | No. of subjects | No. of deaths | Mortality rate (per 1000 person-years) | Hazard ratio (95% CI)a | No. of deaths | Mortality rate (per 1000 person-years) | Hazard ratio (95% CI)b | No. of deaths | Mortality rate (per 1000 person-years) | Hazard ratio (95% CI)b |
Total sample | ||||||||||
< 5.18 | 687 | 325 | 71.8 | 1.00 (Ref.) | 205 | 45.3 | 1.00 (Ref.) | 120 | 26.5 | 1.00 (Ref.) |
5.18–6.21 | 1207 | 394 | 43.2 | 0.71 (0.61–0.83) | 236 | 25.9 | 0.82 (0.66–1.02) | 158 | 17.3 | 0.85 (0.66–1.09) |
≥ 6.22 | 1196 | 340 | 35.6 | 0.68 (0.57–0.80) | 221 | 23.2 | 0.98 (0.77–1.23) | 119 | 12.5 | 0.67 (0.51–0.88) |
P for trend | <0.001a | 0.882b | 0.004b | |||||||
No use of cholesterol-lowering medications | ||||||||||
< 5.18 | 495 | 259 | 84.7 | 1.00 (Ref.) | 162 | 53.0 | 1.00 (Ref.) | 97 | 31.7 | 1.00 (Ref.) |
5.18–6.21 | 1066 | 358 | 44.7 | 0.70 (0.59–0.82) | 213 | 26.6 | 0.79 (0.63–1.00) | 145 | 18.1 | 0.88 (0.67–1.16) |
≥ 6.22 | 1140 | 324 | 35.5 | 0.65 (0.54–0.77) | 209 | 22.9 | 0.91 (0.72–1.17) | 115 | 12.6 | 0.69 (0.51–0.92) |
P for trend | <0.001a | 0.573b | 0.009b | |||||||
Use of cholesterol-lowering medications | ||||||||||
< 5.18 | 189 | 64 | 44.0 | 1.00 (Ref.) | 42 | 28.9 | 1.00 (Ref.) | 22 | 15.1 | 1.00 (Ref.) |
5.18–6.21 | 138 | 33 | 29.6 | 0.76 (0.49–1.19) | 22 | 19.7 | 0.84 (0.47–1.50) | 11 | 9.9 | 0.75 (0.35–1.61) |
≥ 6.22 | 54 | 14 | 33.2 | 1.03 (0.56–1.90) | 11 | 26.0 | 1.47 (0.77–2.81) | 3 | 7.1 | 0.52 (0.14–1.98) |
P for trend | 0.961a | 0.561b | 0.244b |